- 영문명
- Combined Therapy of Intravitreal Bevacizumab and Posterior Subtenon Triamcinolone Injection in Macular Edema with Branch Retinal Vein Occlusion
- 발행기관
- 대한안과학회
- 저자명
- 조아란 최경식 이미리 이성진,Aran Cho, MD, Kyung Seek Choi, MD, PhD, Mi Ri Rhee, MD, Sung Jin Lee, MD, PhD
- 간행물 정보
- 『대한안과학회지』Ophthalmological Society,volume53,number2, 276~282쪽, 전체 7쪽
- 주제분류
- 인문학 > 역사학
- 파일형태
- 발행일자
- 2012.02.15

국문 초록
영문 초록
Purpose: To compare the clinical outcomes of intravitreal bevacizumab with and without posterior subtenon triamcinolone acetonide injections for macular edema with branch retinal vein occlusion. Methods: Intravitreal bevacizumab injection (single group) or intravitreal bevacizumab injection with posterior subtenon triamcinolone acetonide injection (combined group) were performed in 30 eyes each, and intravitreal bevacizumab injection was given once a month in both groups until macular edema was in the normal range. A best corrected visual acuity and central macular thickness were measured pre- and post- injection. Results: The required number of injections to achieve improved macular edema in the normal range was 2.8 ± 0.5 times in the single group and 2.0 ± 0.6 times in the combined group. Six months after injection, average central macular thickness decreased to 185.3 ± 63.5 μm in the single group and to 260.0 ± 74.6 μm in the combined group. The best corrected visual acuity (log MAR) improved from 0.71 ± 0.63 to 0.35 ± 0.44 in the single group and from 0.67 ± 0.42 to 0.08 ± 0.11 in the combined group. The number of cases in which the central macular thickness increased again within 6 months after the injections was 19 eyes in the single group and 6 eyes in the combined group. Conclusions: In macular edema with branch retinal vein occlusion, early rapid recovery of visual acuity and decrease of central macular thickness were observed due to the synergistic effect of bevacizumab and triamcinolone acetonide in combined therapy, and the recurrence frequency of macular edema was reduced by the long-term effect instilled by the long half-life of triamcinolone acetonide. J Korean Ophthalmol Soc 2012;53(2):276-282
목차
해당간행물 수록 논문
참고문헌
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!
